Drugmaker Recalls Arthritis Medication

Article

WASHINGTON - ESI Lederle announced last Thursday that it was recalling 4.2 million capsules of the arthritis drug etodolac because of contamination that could cause life-threatening complications in patients with heart conditions.

The company said that the recall will cover one lot of 300-milligram capsules, No. 9991052, which were distributed nationwide. For more information visit www.fda.gov.

Related Videos
Jill Holdsworth, MS, CIC, FAPIC, CRCST, NREMT, CHL
Jill Holdsworth, MS, CIC, FAPIC, CRCSR, NREMT, CHL, and Katie Belski, BSHCA, CRCST, CHL, CIS
Baby visiting a pediatric facility  (Adobe Stock 448959249 by Rawpixel.com)
Antimicrobial Resistance (Adobe Stock unknown)
Anne Meneghetti, MD, speaking with Infection Control Today
Patient Safety: Infection Control Today's Trending Topic for March
Infection Control Today® (ICT®) talks with John Kimsey, vice president of processing optimization and customer success for Steris.
Picture at AORN’s International Surgical Conference & Expo 2024
Infection Control Today and Contagion are collaborating for Rare Disease Month.
Related Content